Antiemetic Drugs Strategic Research Report 2024-2030: Pharmacogenomics and Personalized Medicine Shape the Future of Developments, Rising Cancer Rates and Chemotherapy Demand Fuel Expansion Dublin, Aug. 27, 2024 (GLOBE NEWSWIRE) -- The "Antiemetic Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Antiemetic Drugs...

Global Gastroparesis Treatment Market to Surpass US$ 10,726.0 Million by 2030, Says Coherent Market Insights (CMI) Seattle, Aug. 18, 2022 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global gastroparesis treatment market is estimated to be valued at US$ 8,061.9 million in 2022 and expected to...

Neurogastrx Appoints Baxter Phillips III as President and Chief Executive Officer CAMPBELL, Calif., Nov. 03, 2015 (GLOBE NEWSWIRE) -- Neurogastrx, a biopharmaceutical company engaged in developing novel drugs for gastrointestinal disorders, today announced the appointment of...